La Rosa et al., following MCI patients for 2 years, found that blood samples collected at baseline had higher PBMC mRNA levels of IL-1β and IL-6 in AD converters than in non-converters only if the samples were stimulated with Aβ, suggesting that an inflammatory milieu may contribute specifically to the onset of AD [113]. This evidence concerns the gene IL1B and Alzheimer disease.